Evidence map›Paper›PMID 25514749›Full record

ArticlePloS one2014

Novel expression vectors enabling induction of gene expression by small-interfering RNAs and microRNAs.

Liraz Harel, Nir Gefen, Ofira Carmi, Pini Orbach, Paz Einat, Guy Abitbol

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liraz HarelNanodoc Biotechnology, 7 Sapir Str., Nes Ziona 7403630, Israel.
Nir GefenNanodoc Biotechnology, 7 Sapir Str., Nes Ziona 7403630, Israel.
Ofira CarmiNanodoc Biotechnology, 7 Sapir Str., Nes Ziona 7403630, Israel.
Pini OrbachNanodoc Biotechnology, 7 Sapir Str., Nes Ziona 7403630, Israel.
Paz EinatDr. Paz Einat Biotechnology Projects & Consulting, 45a Moshe Levi Str., Nes Ziona 74207, Israel.
Guy AbitbolNanodoc Biotechnology, 7 Sapir Str., Nes Ziona 7403630, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small-interfering RNAs and microRNAs are small ∼21-22 nucleotide long RNAs capable of posttranscriptional suppression of gene expression. The synthetic siRNAs are especially designed to target pre-specified genes and are common molecular biology tools. The miRNAs are endogenous regulators of gene expression found in a wide variety of eukaryotes. miRNAs are currently utilized for diagnostics applications. Therapeutically, various miRNA-antagonizing tools are being explored and miRNAs are also utilized for cell-specific inhibition of the expression of gene therapy vectors harboring target sites for specific miRNAs. Here we show, for the first time, that siRNAs and miRNAs can be harnessed to induce gene expression. We designed special expression vectors in which target sites for artificial siRNAs or endogenous miRNAs are located between the transgene and an Upstream Inhibitory Region (UIR). We hypothesized that cleavage of the mRNA by siRNAs or miRNAs will separate the transgene from the UIR and the resulting uncapped mRNA will be capable of being translated. A UIR composed of seven open reading frames was found to be the most efficient inhibitor of the translation of the downstream transgene. We show that under such a configuration both artificial siRNAs and endogenous miRNAs were capable of inducing transgene expression. We show that using the diphtheria toxin A-chain gene, in combination with target sites for highly expressed miRNAs, specific induction of cell-death can be achieved, setting the stage for application to cancer therapy.

Indexed as

Diphtheria ToxinGene Expression ProfilingGene Expression RegulationGenetic TherapyGenetic VectorsHEK293 CellsHumansMicroRNAsOpen Reading FramesPeptide FragmentsRegulatory Sequences, Nucleic AcidRNA, Small InterferingTransgenesDiphtheria Toxindiphtheria toxin fragment AMicroRNAsPeptide FragmentsRNA, Small Interfering

Identifiers

PMID25514749
PMCPMC4267845
OpenAlexW1995788872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.